Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Plasmodium falciparum 3D7 | M1-family aminopeptidase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.1809 | 0.2425 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.0704 | 0.0633 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0067 | 0.13 | 0.167 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0067 | 0.13 | 0.167 |
Schistosoma mansoni | P2X receptor subunit | 0.0067 | 0.13 | 0.8286 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0101 | 0.0136 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0706 | 0.0946 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.7462 | 1 |
Toxoplasma gondii | aminopeptidase N, putative | 0.0375 | 1 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0166 | 0.0137 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0166 | 0.0137 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1042 | 0.1102 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.7462 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1433 | 0.185 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0787 | 0.1054 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0166 | 0.0679 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.1955 | 0.2368 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0067 | 0.13 | 0.167 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0623 | 0.0754 |
Brugia malayi | hypothetical protein | 0.0286 | 0.7462 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1433 | 0.185 |
Plasmodium vivax | M1-family alanyl aminopeptidase, putative | 0.0375 | 1 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.1556 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0067 | 0.13 | 0.167 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0852 | 0.1142 |
Onchocerca volvulus | 0.0058 | 0.1042 | 0.5 | |
Schistosoma mansoni | P2X receptor subunit | 0.0067 | 0.13 | 0.8286 |
Toxoplasma gondii | aminopeptidase n, putative | 0.0375 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0101 | 0.0242 |
Toxoplasma gondii | aminopeptidase N protein | 0.0375 | 1 | 0.5 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0067 | 0.13 | 0.167 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1042 | 0.6557 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.7462 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0623 | 0.0754 |
Schistosoma mansoni | P2X receptor subunit | 0.0067 | 0.13 | 0.8286 |
Schistosoma mansoni | P2X receptor subunit | 0.0067 | 0.13 | 0.8286 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1042 | 0.6557 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0067 | 0.13 | 0.167 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 17.78 um | PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP). Inhibition of the rate of hydrolysis of fluorogenic peptide substrate (H-Leu-NHMec). Secondary screen (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 21.1923 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.